Isu Abxis has newly appeared among the top searched stocks.


As of 10:31 AM on the 31st, Isu Abxis is trading at 10,200 KRW, up 0.49% from the previous day. This represents a 44.89% increase compared to July 31. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.

Over the past five days, individual investors have net purchased 67,593 shares, while foreigners and institutions have net purchased 44,982 shares and net sold 50,545 shares, respectively.


On August 28, Isu Abxis became a market issue with the headline "Early session 15% surge 'Safety and efficacy trial for head and neck cancer patients'".



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing